{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:32:44Z","timestamp":1779183164169,"version":"3.51.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.arbres.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T02:00:55Z","timestamp":1405994455000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diagn\u00f3stico y tratamiento del mesotelioma pleural maligno"],"prefix":"10.1016","volume":"51","author":[{"given":"Francisco","family":"Rodr\u00edguez Panadero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2014.06.005_bib0005","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","article-title":"Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey","volume":"357","author":"Roushdy-Hammady","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2014.06.005_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1579-2129(06)60416-3","article-title":"Normativa sobre el asbesto y sus enfermedades pleuropulmonares","volume":"41","author":"Isidro Montes","year":"2005","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.arbres.2009.04.007","article-title":"Enfermedad por amianto en una poblaci\u00f3n pr\u00f3xima a una f\u00e1brica de fibrocemento","volume":"45","author":"Tarr\u00e9s","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oxfordjournals.aje.a009616","article-title":"Pleural mesothelioma: Dose-response relation at low levels of asbestos exposure in a French population-based case-control study","volume":"148","author":"Iwatsubo","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/oem.56.8.505","article-title":"Mesothelioma: Cases associated with non-occupational and low dose exposures","volume":"56","author":"Hillerdal","year":"1999","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1164\/rccm.2507003","article-title":"Can exposure to very low levels of asbestos induce pleural mesothelioma?","volume":"172","author":"Goldberg","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0040","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(07)60412-7","article-title":"Ecological association between asbestos-related diseases and historical asbestos consumption: An international analysis","volume":"369","author":"Lin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2014.06.005_bib0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/030089161109700204","article-title":"Malignant mesothelioma of the pleura in nonagenarian patients","volume":"97","author":"Bianchi","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.arbres.2014.06.005_bib0050","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/rg.241035058","article-title":"Malignant pleural mesothelioma: Evaluation with CT MR imaging, and PET","volume":"24","author":"Wang","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.arbres.2014.06.005_bib0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1510\/icvts.2010.255901","article-title":"Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?","volume":"12","author":"Sharif","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PET\/CT imaging in the clinical management of malignant pleural mesothelioma: Emerging significance of image segmentation and global disease assessment","volume":"13","author":"Basu","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1510\/icvts.2010.255893","article-title":"What is the best way to diagnose and stage malignant pleural mesothelioma?","volume":"12","author":"Zahid","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-13-12","article-title":"Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma","volume":"13","author":"Shinohara","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.arbres.2014.06.005_bib0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3892\/ol_00000146","article-title":"Usefulness of (18)F-FDG positron emission tomography\/computed tomography for the diagnosis of pyothorax-associated lymphoma: A report of three cases","volume":"1","author":"Abe","year":"2010","journal-title":"Oncol Lett"},{"key":"10.1016\/j.arbres.2014.06.005_bib0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000356752","article-title":"Positive FDG-PET\/CT of the pleura twenty years after talc pleurodesis: Three cases of benign talcoma","volume":"87","author":"Vandemoortele","year":"2014","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2014.06.005_bib0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/RLI.0b013e3181817b3d","article-title":"Computed tomography, positron emission tomography, positron emission tomography\/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: Initial results","volume":"43","author":"Plathow","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.resinv.2013.02.002","article-title":"Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma","volume":"51","author":"Fujimoto","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.arbres.2014.06.005_bib0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","article-title":"Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma","volume":"82","author":"Creaney","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0105","first-page":"259","article-title":"Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?","volume":"65","author":"Ogata","year":"2011","journal-title":"Acta Med Okayama"},{"issue":"Suppl 3","key":"10.1016\/j.arbres.2014.06.005_bib0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0300-2896(09)72854-6","article-title":"Manejo de la patolog\u00eda pleural","volume":"45","author":"Rodr\u00edguez-Panadero","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcp\/110.3.397","article-title":"Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: A brief review","volume":"110","author":"Henderson","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0125","doi-asserted-by":"crossref","unstructured":"British Thoracic Society Standards of Care Committee BTS statement on malignant mesothelioma in the UK, 2007. Thorax. 2007;62 Suppl 2:ii1-ii19.","DOI":"10.1136\/thx.2007.087619"},{"key":"10.1016\/j.arbres.2014.06.005_bib0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0135","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"Van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.arbres.2014.06.005_bib0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2014.06.005_bib0145","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(03)13079-6","article-title":"Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: A randomised controlled trial","volume":"361","author":"Maskell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2014.06.005_bib0150","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1378\/chest.09-0884","article-title":"Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: A randomized, controlled trial","volume":"137","author":"Metintas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2014.06.005_bib0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2012.09.004","article-title":"Analysis of \u00abdry\u00bb mesothelioma with ultrasound guided biopsies","volume":"78","author":"Stigt","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2559.2008.03099.x","article-title":"The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma","volume":"53","author":"Attanoos","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.arbres.2014.06.005_bib0165","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2009.02.023","article-title":"A local anaesthetic video-assisted thoracoscopy service: Prospective performance analysis in a UK tertiary respiratory centre","volume":"66","author":"Medford","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000158545","article-title":"Medical thoracoscopy","volume":"76","author":"Rodr\u00edguez-Panadero","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2014.06.005_bib0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-642-10862-4_4","article-title":"Biopsy techniques for the diagnosis of mesothelioma","volume":"189","author":"Walters","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.arbres.2014.06.005_bib0180","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/cncr.23034","article-title":"Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma","volume":"110","author":"Greillier","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0185","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0190","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arbres.2014.06.005_bib0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-12-394384-2.00006-1","article-title":"Asbestos-related disease: Screening and diagnosis","volume":"57","author":"Rodr\u00edguez Portal","year":"2012","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.arbres.2014.06.005_bib0200","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: An individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1183\/09031936.00148211","article-title":"A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions","volume":"41","author":"Hooper","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2014.06.005_bib0210","doi-asserted-by":"crossref","first-page":"e004145","DOI":"10.1136\/bmjopen-2013-004145","article-title":"Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis","volume":"4","author":"Cui","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.arbres.2014.06.005_bib0215","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.00226111","article-title":"Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma","volume":"41","author":"Pantazopoulos","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2014.06.005_bib0220","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0225","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0230","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","article-title":"Identification of novel markers for the diagnosis of malignant pleural mesothelioma","volume":"178","author":"Gueugnon","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0235","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jclinpath-2013-201609","article-title":"Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0240","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","article-title":"Identification of hundreds of conserved and nonconserved human microRNAs","volume":"37","author":"Bentwich","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.arbres.2014.06.005_bib0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Benjamin","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.arbres.2014.06.005_bib0250","doi-asserted-by":"crossref","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","article-title":"Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma. A pilot study","volume":"7","author":"Weber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2014.06.005_bib0255","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2010.04.004","article-title":"Malignant pleural mesothelioma: The standard of care and challenges for future management","volume":"78","author":"Van Meerbeeck","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0265","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-5223(19)38932-9","article-title":"Surgical treatment of pleural mesothelioma","volume":"84","author":"McCormack","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.semtcvs.2009.06.008","article-title":"Surgical options in malignant pleural mesothelioma: Extrapleural pneumonectomy or pleurectomy\/decortication","volume":"21","author":"Flores","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0275","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semtcvs.2009.07.007","article-title":"Surgical techniques for multimodality treatment of malignant pleural mesothelioma: Extrapleural pneumonectomy and pleurectomy\/decortication","volume":"21","author":"Wolf","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","article-title":"Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure","volume":"77","author":"Rena","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0285","doi-asserted-by":"crossref","first-page":"272S","DOI":"10.1378\/chest.112.4_Supplement.272S","article-title":"Multimodality therapy for malignant pleural mesothelioma","volume":"112","author":"Sugarbaker","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2014.06.005_bib0290","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to ii study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0295","first-page":"1362","article-title":"Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: Updated meta-analysis","volume":"36","author":"Van Schil","year":"2010","journal-title":"BMJ Open"},{"key":"10.1016\/j.arbres.2014.06.005_bib0300","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejso.2004.08.014","article-title":"Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma","volume":"31","author":"Halstead","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/JTO.0b013e31824d9a52","article-title":"Is it time to consider pleurectomy and decortication as the only surgical treatment for malignant pleural mesothelioma?","volume":"7","author":"Weyant","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0315","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejcts.2007.01.064","article-title":"Case-control study between extrapleural pneumonectomy and radical pleurectomy\/decortication for pathological N2 malignant pleural mesothelioma","volume":"31","author":"Martin-Ucar","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: Conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0330","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/JTO.0b013e31824ab6c5","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0335","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/JTO.0b013e318272601f","article-title":"Tomotherapy after pleurectomy\/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung","volume":"7","author":"Minatel","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0340","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1634\/theoncologist.2010-0185","article-title":"What is the role of radiotherapy in malignant pleural mesothelioma?","volume":"16","author":"Price","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.arbres.2014.06.005_bib0345","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0360-3016(98)00409-X","article-title":"Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients","volume":"43","author":"De Graaf-Strukowska","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arbres.2014.06.005_bib0350","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.ejca.2011.05.012","article-title":"Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma","volume":"47","author":"Jenkins","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.arbres.2014.06.005_bib0355","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0936-6555(05)80540-0","article-title":"Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy","volume":"7","author":"Low","year":"1995","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.arbres.2014.06.005_bib0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(03)00229-9","article-title":"Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: A Dutch-Belgian survey","volume":"68","author":"De Ruysscher","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0365","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0370","first-page":"508","article-title":"Chemotherapy for malignant pleural mesothelioma: A review of current management and a look to the future","volume":"1","author":"Nowak","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.arbres.2014.06.005_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-011-1655-3","article-title":"Review on clinical trials of targeted treatments in malignant mesothelioma","volume":"68","author":"Jakobsen","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0380","article-title":"Mesothelin targeted chemo-immunotherapy for treatment of malignant mesothelioma and lung adenocarcinoma","author":"Hassan","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0385","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1165\/rcmb.2013-0472TR","article-title":"Immunotherapy for malignant pleural mesothelioma. Current status and future prospects","volume":"50","author":"Wong","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0390","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1164\/rccm.200909-1465OC","article-title":"Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma","volume":"181","author":"Hegmans","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0395","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000339259","article-title":"Malignant pleural mesothelioma. From the bench to the bedside","volume":"83","author":"Astoul","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2014.06.005_bib0400","doi-asserted-by":"crossref","first-page":"e81919","DOI":"10.1371\/journal.pone.0081919","article-title":"Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2014.06.005_bib0405","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000335419","article-title":"Mechanisms of pleurodesis","volume":"83","author":"Rodriguez-Panadero","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2014.06.005_bib0410","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00408-011-9283-6","article-title":"Tumor type influences the effectiveness of pleurodesis in malignant effusions","volume":"189","author":"Bielsa","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.arbres.2014.06.005_bib0415","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.arbres.2009.09.009","article-title":"Uso del drenaje pleural permanente en el manejo ambulatorio del derrame pleural maligno recidivante","volume":"45","author":"Cases","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: A systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0425","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion. The TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.arbres.2014.06.005_bib0430","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0269216314521851","article-title":"Quality-of-life assessment in malignant pleural effusion treated with indwelling pleural catheter: A prospective study","volume":"28","author":"Lorenzo","year":"2014","journal-title":"Palliat Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0435","first-page":"1925","article-title":"From molecular imaging in preclinical\/clinical oncology to theranostic applications in targeted tumor therapy","volume":"16","author":"Alberti","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.arbres.2014.06.005_bib0440","doi-asserted-by":"crossref","first-page":"747416","DOI":"10.1155\/2012\/747416","article-title":"Molecular imaging-guided theranostics and personalized medicine","volume":"2012","author":"Zhang","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0445","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-08-1363","article-title":"Identification of MCAM\/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma","volume":"69","author":"Bidlingmaier","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.arbres.2014.06.005_bib0450","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1158\/0008-5472.CAN-06-3315","article-title":"A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched Avidin-Rhodamine conjugate","volume":"67","author":"Hama","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.arbres.2014.06.005_bib0455","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00330-002-1524-x","article-title":"Fluorescence imaging with near-infrared light: New technological advances that enable in vivo molecular imaging","volume":"13","author":"Ntziachristos","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mrm.20010","article-title":"Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI","volume":"51","author":"Morawski","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.arbres.2014.06.005_bib0465","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiol.12121021","article-title":"Orthotopic pleural mesothelioma in mice: SPECT\/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies","volume":"26","author":"Nayak","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2014.06.005_bib0470","doi-asserted-by":"crossref","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","article-title":"Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool","volume":"7","author":"Ostroff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2014.06.005_bib0475","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1074\/mcp.M113.030775","article-title":"Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma","volume":"13","author":"Mundt","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.arbres.2014.06.005_bib0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11864-011-0153-5","article-title":"Gene therapy for mesothelioma","volume":"12","author":"Vachani","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.arbres.2014.06.005_bib0485","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000337060","article-title":"Novel intrapleural therapies for malignant diseases","volume":"83","author":"Haas","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2014.06.005_bib0490","doi-asserted-by":"crossref","first-page":"572609","DOI":"10.1155\/2013\/572609","article-title":"A potential therapeutic strategy for malignant mesothelioma with gene medicine","volume":"2013","author":"Tada","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.arbres.2014.06.005_bib0495","doi-asserted-by":"crossref","first-page":"e85935","DOI":"10.1371\/journal.pone.0085935","article-title":"MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma","volume":"9","author":"Melaiu","year":"2014","journal-title":"PLoS One"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614002270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614002270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T13:02:29Z","timestamp":1598101349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289614002270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0300289614002270"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2014.06.005","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico y tratamiento del mesotelioma pleural maligno","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}